The invention relates to a chewing tablet taking acarbose as an active component.
本发明涉及一种以阿卡波糖为活性成份的咀嚼片。
The top 3 hypoglycemic drugs in respect of sales amount were acarbose, gliclazide, and glipizide.
用药金额排名前3位的药物是阿卡波糖、格列齐特、格列吡嗪。
In this paper, the techniques of fermentation, separation and purification of acarbose were studied.
本论文对阿卡波糖的发酵及分离纯化工艺进行了深入的研究。
Objective To evaluate the therapeutic effect of acarbose on reactive hypoglycemia after subtotal gastrectomy.
目的探讨阿卡波糖对胃大部切除术后患者出现餐后反应性低血糖的临床疗效。
Objective To investigate the effect of combination therapy of insulin and acarbose on glucose excursion in diabetic patients.
目的观察胰岛素治疗联合阿卡波糖对血糖波动的影响。
OBJECTIVE:To evaluate the cost-effectiveness of domestic versus imported acarbose tablets in the treatment of type 2 diabetic mellitus.
前言： 目的：比较国产与进口阿卡波糖片治疗2型糖尿病的成本-效果。
Objective: To observe the clinical efficacy and safety of combined treatment of repaglinide and acarbose in aged patients with diabetes type 2.
目的：观察瑞格列奈、阿卡波糖联合治疗老年性2型糖尿病患者的临床疗效及安全性。
Conclusion Application of acarbose in the intervening treatment of IGT subjects can reduce the incidence of diabetes and without increase the secretion of insulin.
结论阿卡波糖能够降低IGT人群糖尿病的发病率，且不增加胰岛素的分泌。
Objective To compare the effects between biphasic insulin injection(Novolin 30R) alone and its therapeutic alliance with acarbose on type 2 diabetes mellitus(T2DM).
目的比较双相胰岛素注射剂（诺和灵30R）单用和联合阿卡波糖治疗2型糖尿病的疗效。
To observe the effect of combination therapy of acarbose and Liuwei Nengxiao capsule (LWNXC) in improving senile postprandial hyperglycemia and insulin sensitivity.
目的观察阿卡波糖合用六味能消胶囊降低餐后血糖、改善胰岛素敏感性的作用。
The acarbose is taken as the medical active component, and the acarbose is mixed with a pharmaceutically acceptable auxiliary material to form the drug composition.
它是以阿卡波糖为药用活性成份，与药学上可接受的辅料混合形成的药用组合物。
Objective: To study the efficiency and safety of the domestic and imported acarbose in type 2 diabetes patients, and the effect on insulin levels, body weight and serum lipids.
前言：目的：比较国产和进口阿卡波糖的降糖效果和安全性，及其对胰岛素水平、体重及血脂的影响。
Objective: To observe the clinical efficacy of insulin glargine, acarbose and benazepril in the combined treatment of early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).
目的：观察甘精胰岛素、阿卡波糖与盐酸贝那普利联合治疗2型糖尿病早期肾病的临床疗效。
Conclusions Acarbose was an effective and safe drug in lowering postprandial hyperglycemia.
结论阿卡波糖是降低餐后高血糖的一种有效而安全的降糖药。
So for all those reasons I think that for the prevention of diabetes, Acarbose has to be a priority.
总之，我认为，对于糖尿病的预防，阿卡波糖为首选。
Objective to investigate the therapeutic efficacy of Acarbose on patients with impaired glucose tolerance.
目的观察阿卡波糖对糖耐量异常患者的治疗效果。
Objective To observe the effect and side effect of Glipizide XL combined with Acarbose on patients with type 2 diabetes mellitus(T2DM).
目的观察瑞易宁和拜唐苹联合治疗初发2型糖尿病的疗效及安全性。
METHODS:The CORE diabetes model was employed to evaluate the long-term cost-effectiveness of Acarbose in the treatment of type 2 diabetes.
方法：运用CORE糖尿病模型评价阿卡波糖治疗2型糖尿病的长期成本与效果。
METHODS:The CORE diabetes model was employed to evaluate the long-term cost-effectiveness of Acarbose in the treatment of type 2 diabetes.
方法：运用CORE糖尿病模型评价阿卡波糖治疗2型糖尿病的长期成本与效果。
应用推荐